These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 22380808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection.
    Iris Kalli, Leontides LS, Mylonakis ME, Adamama-Moraitou K, Rallis T, Koutinas AF.
    Res Vet Sci; 2010 Oct; 89(2):174-8. PubMed ID: 20303134
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of hyperimmune plasma for treatment of dogs with naturally occurring parvoviral enteritis.
    Acciacca RA, Sullivan LA, Webb TL, Johnson V, Dow SW.
    J Vet Emerg Crit Care (San Antonio); 2020 Sep; 30(5):525-533. PubMed ID: 32705762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
    Proksch AL, Unterer S, Truyen U, Hartmann K.
    Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A survey of canine parvovirus-2 in Albania.
    Kusi I.
    Dtsch Tierarztl Wochenschr; 1997 Nov; 104(11):478-80. PubMed ID: 9429323
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of oseltamivir in the treatment of canine parvoviral enteritis.
    Savigny MR, Macintire DK.
    J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):132-42. PubMed ID: 20230441
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.
    Otto CM, Jackson CB, Rogell EJ, Prior RB, Ammons WS.
    J Vet Intern Med; 2001 Feb; 15(4):355-60. PubMed ID: 11467593
    [Abstract] [Full Text] [Related]

  • 15. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
    Banse HE, McKenzie EC, Nelson S, Hinchcliff KW.
    J Am Vet Med Assoc; 2008 Jun 01; 232(11):1669-73. PubMed ID: 18518808
    [Abstract] [Full Text] [Related]

  • 16. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ, Schultz RD.
    Am J Vet Res; 1997 Apr 01; 58(4):360-3. PubMed ID: 9099379
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997-2000).
    Mantione NL, Otto CM.
    J Am Vet Med Assoc; 2005 Dec 01; 227(11):1787-93. PubMed ID: 16342528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isolation, molecular characterization and phylogenetic analysis of canine parvovirus.
    Mohan Raj J, Mukhopadhyay HK, Thanislass J, Antony PX, Pillai RM.
    Infect Genet Evol; 2010 Dec 01; 10(8):1237-41. PubMed ID: 20723622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.